Literature DB >> 15616390

A single-pass batch dialysis system: an ideal dialysis method for the patient in intensive care with acute renal failure.

Danilo Fliser1, Jan T Kielstein.   

Abstract

PURPOSE OF REVIEW: Conventional intermittent hemodialysis and continuous veno-venous hemofiltration are the opposite poles of current treatment modalities for patients with acute renal failure in the intensive care unit. Because both intermittent and continuous renal replacement techniques have several disadvantages, alternative treatment strategies have been developed. This review summarizes relevant information on these new hybrid techniques, and special attention is paid to the use of a single-pass batch dialysis system in the intensive care unit. RECENT
FINDINGS: Prospective controlled studies have been published from several centers that use standard dialysis equipment for hybrid techniques, called sustained low-efficiency dialysis or slow extended dialysis. Their common therapeutic aim is to provide an easy-to-perform treatment with reduced solute clearances maintained for prolonged periods of time. These studies have documented that sustained low-efficiency dialysis offers (1) solute removal that is comparable with that obtained with intermittent hemodialysis and continuous veno-venous hemofiltration, even if high substitution fluid rates are used, (2) cardiovascular tolerability like that observed with continuous veno-venous hemofiltration, (3) significantly reduced heparin use in comparison with continuous veno-venous hemofiltration, (4) simple handling and high acceptance by the intensive care unit staff, (5) reduced treatment costs, and (6) the possibility of nocturnal treatments, allowing unrestricted patient access for daytime procedures.
SUMMARY: Sustained low-efficiency dialysis is increasingly being used as renal replacement therapy in critically ill patients in the intensive care unit. It combines several advantages of both intermittent and continuous techniques. The procedural simplicity, particularly if single-pass batch dialysis is used, makes it an ideal treatment for patients with renal failure in the intensive care unit.

Entities:  

Mesh:

Year:  2004        PMID: 15616390     DOI: 10.1097/01.ccx.0000145101.58940.dc

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  6 in total

Review 1.  [Renal replacement therapy in the intensive care unit].

Authors:  C Morath; N Miftari; R Dikow; C Hainer; M Zeier; V Schwenger; M A Weigand
Journal:  Anaesthesist       Date:  2006-08       Impact factor: 1.041

2.  Sustained low-efficiency extended dialysis (SLED) with single-pass batch system in critically-ill patients with acute kidney injury (AKI).

Authors:  Renato A Caires; Regina C R M Abdulkader; Verônica T Costa E Silva; Gillene S Ferreira; Emmanuel A Burdmann; Luis Yu; Etienne Macedo
Journal:  J Nephrol       Date:  2015-08-23       Impact factor: 3.902

3.  [Mobile single-pass batch hemodialysis system in intensive care medicine. Reduction of costs and workload in renal replacement therapy].

Authors:  H-B Hopf; M Hochscherf; M Jehmlich; M Leischik; J Ritter
Journal:  Anaesthesist       Date:  2007-07       Impact factor: 1.041

4.  Elimination of fosfomycin during dialysis with the Genius system in septic patients.

Authors:  T Dimski; T Brandenburger; M Janczyk; T Slowinski; C MacKenzie; D Kindgen-Milles
Journal:  Sci Rep       Date:  2021-06-08       Impact factor: 4.379

5.  Sustained low efficiency dialysis using a single-pass batch system in acute kidney injury - a randomized interventional trial: the REnal Replacement Therapy Study in Intensive Care Unit PatiEnts.

Authors:  Vedat Schwenger; Markus A Weigand; Oskar Hoffmann; Ralf Dikow; Lars P Kihm; Jörg Seckinger; Nexhat Miftari; Matthias Schaier; Stefan Hofer; Caroline Haar; Peter P Nawroth; Martin Zeier; Eike Martin; Christian Morath
Journal:  Crit Care       Date:  2012-07-27       Impact factor: 9.097

6.  Cotrimoxazole plasma levels, dialyzer clearance and total removal by extended dialysis in a patient with acute kidney injury: risk of under-dosing using current dosing recommendations.

Authors:  Christian Clajus; W Nikolaus Kühn-Velten; Julius J Schmidt; Johan M Lorenzen; Daniel Pietsch; Gernot Beutel; Jan T Kielstein
Journal:  BMC Pharmacol Toxicol       Date:  2013-04-03       Impact factor: 2.483

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.